SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is under pressure as the community debates the sustainability of its circular financing deals with OpenAI and rising concerns about the massive capital expenditures fueling the AI sector. Investors are actively scrutinizing these financial arrangements and broader semiconductor volatility while weighing long-term infrastructure demand against current market skepticism.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is facing sharp volatility as investors react to competitive fears surrounding Chinese memory chip expansion and a broader rotation out of crowded AI trades. Community sentiment is deeply divided, with long-term bulls highlighting strong fundamental demand and backlogs while bears aggressively point to technical breakdowns and excessive valuation concerns.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense volatility and downward pressure as investors aggressively pivot to short positions amid concerns over decelerating automotive margins and broader skepticism toward the company's long-term AI and robotics transition. The community remains deeply polarized, with bears focusing on technical breakdowns and structural weakness, while bulls look for support levels and potential reversal signals in a highly uncertain environment.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is facing significant market volatility as investors weigh the FDA's critical briefing documents against the company's aggressive defense, creating a high-stakes binary event ahead of the upcoming advisory committee meeting. The community is sharply divided, with bulls pointing to the company's claims of an obsolete and misrepresented statistical analysis plan, while bears cite the FDA's concerns over trial methodology and efficacy.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is experiencing heightened volatility as investors weigh concerns over AI infrastructure spending, geopolitical tensions, and potential Federal Reserve rate adjustments. Community discussion is heavily focused on systematic deleveraging risks and the impact of institutional positioning, leading to a polarized environment between bears betting on a deeper correction and bulls searching for support levels.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is currently experiencing high volatility driven by a sell-off in the semiconductor sector, with investors closely monitoring geopolitical tensions and uncertain AI infrastructure capital expenditure. The community remains deeply divided, with some traders viewing the current price action as a major bear trap and buying the dip, while others caution against the inherent risks of holding leveraged ETFs during periods of extreme market instability.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently a focal point for intense debate, as investors weigh strong quarterly revenue growth and data center demand against concerns regarding semiconductor sector valuation, heavy capital spending, and aggressive market manipulation tactics. The community remains deeply divided between those viewing the recent price decline as an irrational reaction to AI infrastructure fears and others who believe the stock is experiencing a necessary correction amidst broader market volatility.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

Semiconductor stocks, tracked by the SMH ETF, are currently experiencing high volatility driven by conflicting investor sentiment regarding the sustainability of AI-related capital expenditure and renewed competitive pressure from emerging Chinese AI models. While many market participants remain focused on semiconductor sector fundamentals and long-term AI infrastructure growth, community discussion is actively split between those positioning for a rebound and others cautioning against potential further downside due to aggressive sector rotation and macroeconomic concerns.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently trending as shareholders grapple with a sharp post-IPO selloff that has erased a significant portion of its market value, leading to intense debates over its valuation and the upcoming expiration of share lock-up periods. The community is sharply divided between retail bears anticipating further declines due to impending share unlocks and long-term bulls who remain focused on Musk's ambitious infrastructure projects, like Starlink and data center expansions, as the primary catalysts for future recovery.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending amid broad market volatility fueled by intense debates over AI capital expenditures, the potential for a surprising Federal Reserve rate hike, and significant deleveraging ripples from the South Korean chip sector. Investors are actively discussing the durability of AI-driven growth models and positioning themselves through aggressive short-term hedging as major tech earnings and policy decisions loom.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the second quarter of 2026 on Tuesday, August 4, 2026, following the close of the market. Management will discuss these results in a...

Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories

Elliott Management builds a stake in Bio-Rad (NYSE: BIO) to push for better performance, but family voting control could pose a hurdle.read more...

Bio-Rad to Participate in Upcoming Investor Conferences

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following...

Bio-Rad Laboratories (NYSE:BIO.B) Trading Down 12.8% - Time to Sell?

Bio-Rad Laboratories (NYSE:BIO.B) Trading Down 12.8% - Here's Why...

Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down   - Should You Sell?

Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down - Here's What Happened...

Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from Analysts

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) have earned an average rating of "Hold" from the five brokerages that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendat...

Unlocking Bio-Rad (BIO) International Revenues: Trends, Surprises, and Prospects

Explore how Bio-Rad's (BIO) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Wells Fargo & Company Has Lowered Expectations for Bio-Rad Laboratories (NYSE:BIO) Stock Price

Wells Fargo & Company decreased their target price on Bio-Rad Laboratories from $320.00 to $290.00 and set an "equal weight" rating for the company in a research note on Friday...

Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down Following Weak Earnings

Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down After Earnings Miss...

Bio-Rad Laboratories Q1 Earnings Call Highlights

Bio-Rad Laboratories (NYSE:BIO) reported first-quarter 2026 results that fell within its revenue guidance range, while management emphasized that geopolitical disruption in the Middle East and continued weakness in academic research demand are weighing on growth and profitability expectations for th...

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. The Life Science segment includes development, manufacturing, and marketing of instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. The Clinical Diagnostics segment focuses on designing, manufacturing, marketing, and support of diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

The Fed's July 28-29 meeting has markets debating a hold versus a hike, not a cut, with CME FedWatch pricing roughly a 65% chance of no change and rising odds of a September rate increase amid inflation running well above the 2% target. What do you expect the Fed to decide? Drop a comment with when you expect the first cut/hike to be.

What do you expect the Fed to decide at its FOMC meeting?  
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$316.41
Prev Close	$314.46
Open	$313.45
Dividend Yield	0.00%
50-Day Moving Average	$294.13
Beta	0.92
Avg. Volume	359,183.35
PE Ratio	52.09

52-Week High	$343.12
52-Week Low	$236.73
Market Capitalization	$8.47B
EPS (Annual)	$27.85
Price to Book	1.24
Revenue Per Employee	$346,738.26

Feed

News

Sentiment

Earnings

Fundamentals

Info

BIOBio-Rad Laboratories Inc. - Ordinary Shares - Class A

Latest BIO News